Terms: = Lung cancer AND CBL, RNF55, 867, ENSG00000110395, C-CBL, CBL2 AND Treatment
74 results:
1. Clinical characteristics and MRI based radiomics nomograms can predict iPFS and short-term efficacy of third-generation EGFR-TKI in EGFR-mutated lung adenocarcinoma with brain metastases.
Qi H; Hou Y; Zheng Z; Zheng M; Qiao Q; Wang Z; Sun X; Xing L
BMC Cancer; 2024 Mar; 24(1):362. PubMed ID: 38515096
[TBL] [Abstract] [Full Text] [Related]
2. An Unusual Presentation of Choriocarcinoma in a Postmenopausal Woman: A case report.
Zribi A; Mazroui RA; Sayani R; Burney IA
Sultan Qaboos Univ Med J; 2024 Feb; 24(1):135-138. PubMed ID: 38434469
[TBL] [Abstract] [Full Text] [Related]
3. Pembrolizumab monotherapy for non-small cell lung cancer (NSCLC): can patient stratification be improved in the UK Tayside population? A retrospective cohort study.
Mander ES; Merrick CB; Nicholson HA; Lord HK; Ferguson MJ; Smith G
BMJ Open; 2023 Nov; 13(11):e076715. PubMed ID: 37989364
[TBL] [Abstract] [Full Text] [Related]
4. Application of radiomics based on chest CT-enhanced dual-phase imaging in the immunotherapy of non-small cell lung cancer.
Ma ZP; Li XL; Gao K; Zhang TL; Wang HD; Zhao YX
J Xray Sci Technol; 2023; 31(6):1333-1340. PubMed ID: 37840466
[TBL] [Abstract] [Full Text] [Related]
5. Machine Learning Classifier for Preoperative Prediction of Early Recurrence After Bronchial Arterial Chemoembolization treatment in lung cancer Patients.
Kong C; Lai L; Jin X; Chen W; Ding J; Zheng L; Zhang D; Ying X; Chen X; Chen M; Tu J; Ji J
Acad Radiol; 2023 Dec; 30(12):2880-2893. PubMed ID: 37225529
[TBL] [Abstract] [Full Text] [Related]
6. Sarcopenia and loss of muscle mass in patients with lung cancer undergoing chemotherapy treatment: a systematic review and meta-analysis.
Jensen S; Bloch Z; Quist M; Hansen TTD; Johansen C; Pappot H; Suetta C; Skjødt Rafn B
Acta Oncol; 2023 Mar; 62(3):318-328. PubMed ID: 37051865
[TBL] [Abstract] [Full Text] [Related]
7. In vitro antioxidant, anti-inflammatory, and anticancer activities of mixture Thai medicinal plants.
Jongrungraungchok S; Madaka F; Wunnakup T; Sudsai T; Pongphaew C; Songsak T; Pradubyat N
BMC Complement Med Ther; 2023 Feb; 23(1):43. PubMed ID: 36765341
[TBL] [Abstract] [Full Text] [Related]
8. Cost-effectiveness of nivolumab plus ipilimumab versus chemotherapy as first-line therapy in advanced non-small cell lung cancer.
Shu Y; Ding Y; Li F; Zhang Q
Int Immunopharmacol; 2023 Jan; 114():109589. PubMed ID: 36700770
[TBL] [Abstract] [Full Text] [Related]
9. Effect of chemotherapy, immunotherapy, and targeted therapies on removal of indwelling pleural catheters in non-small cell lung cancer patients with malignant pleural effusions.
Wang M; Sparrow K; Chan C; Gillson A; Stollery D; Li P
Respir Med; 2023 Jan; 206():107093. PubMed ID: 36549515
[TBL] [Abstract] [Full Text] [Related]
10. Pathological Stage N1 Limited-Stage Small-Cell lung cancer Patients Can Benefit From Surgical Resection.
Yu L; Xu J; Qiao R; Han B; Zhong H; Zhong R
Clin Lung Cancer; 2023 Jan; 24(1):e1-e8. PubMed ID: 36085281
[TBL] [Abstract] [Full Text] [Related]
11. Development and externally validate MRI-based nomogram to assess EGFR and T790M mutations in patients with metastatic lung adenocarcinoma.
Fan Y; Dong Y; Wang H; Wang H; Sun X; Wang X; Zhao P; Luo Y; Jiang X
Eur Radiol; 2022 Oct; 32(10):6739-6751. PubMed ID: 35729427
[TBL] [Abstract] [Full Text] [Related]
12. Cost-effectiveness analysis of pegfilgrastim in patients with non-small cell lung cancer receiving ramucirumab plus docetaxel in Japan.
Kondo Y; Tachi T; Sakakibara T; Kato J; Kato A; Mizuno T; Miyake Y; Teramachi H
Support Care Cancer; 2022 Aug; 30(8):6775-6783. PubMed ID: 35524869
[TBL] [Abstract] [Full Text] [Related]
13. Potential benefit of osismertinib plus bevacizumab in leptomeningeal metastasis with EGFR mutant non-small-cell lung cancer.
Yi Y; Cai J; Xu P; Xiong L; Lu Z; Zeng Z; Liu A
J Transl Med; 2022 Mar; 20(1):122. PubMed ID: 35287683
[TBL] [Abstract] [Full Text] [Related]
14. treatment of severe Kaposiform lymphangiomatosis positive for NRAS mutation by MEK inhibition.
Chowers G; Abebe-Campino G; Golan H; Vivante A; Greenberger S; Soudack M; Barkai G; Fox-Fisher I; Li D; March M; Battig MR; Hakonarson H; Adams D; Dori Y; Dagan A
Pediatr Res; 2023 Dec; 94(6):1911-1915. PubMed ID: 35246606
[TBL] [Abstract] [Full Text] [Related]
15. Stabilization of AURKA by the E3 ubiquitin ligase cblC in lung adenocarcinoma.
Hong SY; Lu YC; Hsiao SH; Kao YR; Lee MH; Lin YP; Wang CY; Wu CW
Oncogene; 2022 Mar; 41(13):1907-1917. PubMed ID: 35149839
[TBL] [Abstract] [Full Text] [Related]
16. Pneumonectomy for primary lung cancer: contemporary outcomes, risk factors and model validation.
Brunswicker A; Taylor M; Grant SW; Abah U; Smith M; Shackcloth M; Granato F; Shah R; Rammohan K;
Interact Cardiovasc Thorac Surg; 2022 Jun; 34(6):1054-1061. PubMed ID: 34871415
[TBL] [Abstract] [Full Text] [Related]
17. Evaluation of osimertinib for advanced non-small cell lung cancer with leptomeningeal metastases: a cost-effectiveness and budget impact analysis.
Luo S; Weng X; Lin S; Huang X; Huang L; Zhou W; Guo X; Xu X
Int J Clin Pharm; 2022 Feb; 44(1):192-200. PubMed ID: 34633624
[TBL] [Abstract] [Full Text] [Related]
18. Computed tomography-guided microwave ablation for the treatment of non-small cell lung cancer patients with and without adjacent lobe invasion: A comparative study.
Xu S; Bie ZX; Li YM; Li B; Guo RQ; Li XG
Thorac Cancer; 2021 Oct; 12(20):2780-2788. PubMed ID: 34427998
[TBL] [Abstract] [Full Text] [Related]
19. Combining computed tomography and biologically effective dose in radiomics and deep learning improves prediction of tumor response to robotic lung stereotactic body radiation therapy.
Avanzo M; Gagliardi V; Stancanello J; Blanck O; Pirrone G; El Naqa I; Revelant A; Sartor G
Med Phys; 2021 Oct; 48(10):6257-6269. PubMed ID: 34415574
[TBL] [Abstract] [Full Text] [Related]
20. Novel strategy to treat lung metastases: Hybrid therapy involving surgery and radiofrequency ablation.
Hasegawa T; Kuroda H; Sakakura N; Sato Y; Chatani S; Murata S; Yamaura H; Nakada T; Oya Y; Inaba Y
Thorac Cancer; 2021 Jul; 12(14):2085-2092. PubMed ID: 34106518
[TBL] [Abstract] [Full Text] [Related]
[Next]
